Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 590-593

  Zivanovic, O ^a   Leitao Jr , M M ^a   Park, K J ^a   Zhao, H ^a   Diaz, J P ^a   Konner, J ^a   Alektiar, K ^a   Chi, D S ^a   Abu Rustum, N R ^a   Aghajanian, C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cervix; Platinum based chemotherapy; Small cell neuroendocrine carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PLATINUM DERIVATIVE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; EARLY CANCER; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 60449109704     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.11.010     Document Type: Article

References (19)

1. Reagan J.W., Hamonic M.J., and Wentz W.B. Analytical study of the cells in cervical squamous-cell cancer. Lab. Invest. 6 (1957) 241-250
2. Albores-Saavedra J., Laaraza O., Poucell S., et al. Carcinoid of the uterine cervix: additional observations on a new tumor entity. Cancer 38 (1976) 2328-2342
3. Scully R.D., Aguirre P., and DeLellis R.A. Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. Int. J. Gynecol. Pathol. 3 (1984) 51-70
4. Miller B., Dockter M., el Torky M., and Photopulos G. Small cell carcinoma of the cervix: a clinical and flow-cytometric study. Gynecol. Oncol. 42 (1991) 27-33
5. van Nagell Jr. J.R., Donaldson E.S., Wookd E.G., Maruyama Y., and Utley J. Small cell cancer of the uterine cervix. Cancer 40 (1977) 2243-2249
6. McCusker M.E., Cote T.R., Clegg L.X., and Tavassoli F.J. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol. Oncol. 88 3 (2003) 333-339
7. Sevin B.U., Lu Y., Block D.A., Nadji M., Koechli O.R., and Averette H.E. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 78 (1996) 1438-1446
8. Sheets E.E., Berman M.L., Hrountas C.K., Liao S.Y., and DiSaia P.J. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet. Gynecol. 71 (1988) 10-14
9. Chan J.K., Loizzi V., Burger R.A., Rutgers J., and Monk B.J. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 97 (2003) 568-574
10. Sevin B.U., Method M.W., Nadji M., Lu Y., and Averette H.A. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 77 (1996) 1489-1493
11. Viswanathan A.N., Deavers M.T., Jhingran A., Ramirez P.T., Levenback C., and Eifel P.J. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol. Oncol. 93 (2004) 27-33
12. Boruta II D.M., Schorge J.O., Duska L.A., Crum C.P., Castrillon D.H., and Sheets E.E. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine carcinoma of the uterine cervix. Gynecol. Oncol. 81 (2001) 82-87
13. Abeler V.M., Holm R., Nesland J.M., and Kjørstad K.E. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 73 (1994) 672-677
14. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet. Gynecol. 44 (1974) 265-272
15. Hoskins P.J., Swenerton K.D., Pike J.A., et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J. Clin. Oncol. 21 (2003) 3495-3501
16. Waddell T.K., and Shepherd F.A. Should aggressive surgery ever be part of the management of small cell lung cancer?. Thorac. Surg. Clin. 14 (2004) 271-281
17. Tsuchiya R., Suzuki K., Ichinose Y., et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completed resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J. Thorac. Cardiovasc. Surg. 129 (2005) 977-983
18. Francesco L. Surgery in small-cell lung carcinoma: where is the rationale?. Sem. Surg. Oncol. 21 (2003) 176-181
19. Brock M.V., Hooker C.M., Syphard J.E., et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: its time has come. J. Thorac. Cardiovasc. Surg. 129 (2005) 64-72